Australia
# |
Name |
EBITDA Margin |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
74.73%
|
June 30, 2024 | USD 181.01 | -0.30% |
|
Australia |
|
2 |
29.25%
|
Dec. 31, 2023 | USD 52.00 | -0.29% |
|
Australia |
|
3 |
24.60%
|
June 30, 2024 | USD 2.33 | 0.29% |
|
Australia |
|
4 |
18.57%
|
June 30, 2024 | USD 17.78 | 0.37% |
|
Australia |
|
5 |
14.93%
|
June 30, 2024 | USD 0.74 | 0.02% |
|
Australia |
|
6 |
13.54%
|
June 30, 2024 | USD 1.19 | 3.31% |
|
Australia |
|
7 |
5.11%
|
June 30, 2024 | USD 0.74 | 0.02% |
|
Australia |
|
8 |
2.63%
|
June 30, 2024 | USD 1.89 | -0.64% |
|
Australia |
|
9 |
-17.07%
|
June 30, 2024 | USD 0.85 | -1.43% |
|
Australia |
|
10 |
-388.02%
|
June 30, 2024 | USD 2.34 | -4.83% |
|
Australia |
The Telehealth company in Australia with the highest EBITDA Margin is Pro Medicus Limited (ASX: PME.AX) at 74.73%.
The Telehealth company in Australia with the lowest EBITDA Margin is Clarity Pharmaceuticals Ltd (ASX: CU6.AX) at -388.02%.
The top 10 Telehealth companies in Australia by EBITDA Margin are Pro Medicus Limited, Macquarie Telecom Group Limited, Australian Clinical Labs Limited, Sonic Healthcare Limited, Cogstate Limited, HiTech Group Australia Limited, Monash IVF Group Limited, Integral Diagnostics Limited, Healius Limited and Clarity Pharmaceuticals Ltd.
The bottom 10 Telehealth companies in Australia by EBITDA Margin are Clarity Pharmaceuticals Ltd, Healius Limited, Integral Diagnostics Limited, Monash IVF Group Limited, HiTech Group Australia Limited, Cogstate Limited, Sonic Healthcare Limited, Australian Clinical Labs Limited, Macquarie Telecom Group Limited and Pro Medicus Limited.